Clinical diagnosis and management of breast cancer

ES McDonald, AS Clark, J Tchou, P Zhang… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The diagnosis and management of breast cancer are undergoing a paradigm shift from a
one-size-fits-all approach to an era of personalized medicine. Sophisticated diagnostics …

[HTML][HTML] Functional ferritin nanoparticles for biomedical applications

Z Wang, H Gao, Y Zhang, G Liu, G Niu… - Frontiers of chemical …, 2017 - Springer
Ferritin, a major iron storage protein with a hollow interior cavity, has been reported recently
to play many important roles in biomedical and bioengineering applications. Owing to the …

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer

L Wang, G Tang, K Hu, X Liu, W Zhou, H Li, S Huang… - Radiology, 2022 - pubs.rsna.org
Background Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor (FAPI) has
recently been introduced as a promising tumor imaging agent. Purpose To compare 68Ga …

Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis

HJ Im, K Pak, GJ Cheon, KW Kang, SJ Kim… - European journal of …, 2015 - Springer
Purpose We conducted a comprehensive systematic review of the literature on volumetric
parameters from 18 F-FDG PET and a meta-analysis of the prognostic value of metabolic …

Appropriate use criteria for 18F-FDG PET/CT in restaging and treatment response assessment of malignant disease

H Jadvar, PM Colletti, R Delgado-Bolton… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Precision medicine is evolving to include a variety of data to optimize patient care and
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 …

PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis

RY Chen, LE Dodd, M Lee, P Paripati… - Science translational …, 2014 - science.org
Definitive clinical trials of new chemotherapies for treating tuberculosis (TB) require
following subjects until at least 6 months after treatment discontinuation to assess for …

[HTML][HTML] PET/CT in oncology: current status and perspectives

J Czernin, M Allen-Auerbach, D Nathanson… - Current radiology …, 2013 - Springer
The discovery of the Warburg effect in the early twentieth century followed by the
development of the fluorinated glucose analogue 18 F-fluorodeoxyglucose (18 F-FDG) and …

Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review

G Bentick, J Fairley, S Nadesapillai, I Wicks… - Seminars in Arthritis and …, 2022 - Elsevier
Objectives Positron emission tomography (PET), often combined with computed tomography
(CT), is a well-established tool for diagnosing malignancy and inflammatory disease. The …

[HTML][HTML] Study of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers

C Papin-Michault, C Bonnetaud, M Dufour, F Almairac… - PloS one, 2016 - journals.plos.org
Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be
promising in distinguishing between recurrent tumour and radionecrosis in the follow-up of …

[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective …

MG Hildebrandt, O Gerke, C Baun, K Falch… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To prospectively investigate the diagnostic accuracy of [18F] fluorodeoxyglucose
(FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point …